Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

First Oral Salmonella Vaccine Tested in Mice

XTALKS VITALS NEWS

Salmonella

Salmonella infections are commonly treated using antibiotics, however the emergence of antibiotic-resistant strains of the bacteria are a growing concern.

Share this!

December 22, 2016 | by Sarah Hand, M.Sc.

Salmonella remains one of the most common causes of foodborne illness across the world, however no vaccine exists to prevent against infection with the pathogen. Now, researchers at The University of Texas Medical Branch (UTMB) at Galveston, have developed an oral vaccine for salmonella poisoning.

The researchers originally developed injectable vaccines designed to be effective against three mutated versions of the Salmonella typhimurium bacteria. These studies showed that the experimental vaccines protected mice against a lethal dose of salmonella bacteria.

However, as oral vaccines are easier to administer, the researchers decided to reformulate their injectable preparations. The oral vaccine – the details of which were published in the journal, Frontiers in Cellular and Infection Microbiology – also follows the same digestive pathway as the salmonella bacteria.

“In the current study, we analyzed the immune responses of mice that received the vaccination by mouth as well as how they responded to a lethal dose of salmonella,” said Dr. Ashok Chopra, UTMB professor of microbiology and immunology. “We found that the orally administered vaccines produced strong immunity against salmonella, showing their potential for future use in people.”



Salmonella infections are commonly treated using antibiotics, however the emergence of antibiotic-resistant strains of the bacteria are a growing concern. Salmonella has also been used as a bioweapon; in 1984, a religious cult in rural Oregon contaminated local salad bars, leading to the poisoning of over 700 people.

In the US, about 1.4 million people are infected with salmonella each year, resulting in 15,000 hospitalizations due to salmonellosis and 400 deaths, according to statistics from the Centers for Disease Control and Prevention. While the total number of salmonella infections has stayed consistent since 1996, it’s estimated that for every one diagnosis, 39 infections go unreported.

This new oral salmonella vaccine could go a long way to reducing the 25 percent mortality rate associated with the infection. The vaccine is currently still being assessed in preclinical studies, and has yet to be tested in humans.


Keywords: Salmonella, Oral Vaccine, Foodborne Illness


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Lavazza Acquires Controlling Stake in Canada’s Kicking Horse Coffee

May 26, 2017 - Italian coffee company Lavazza, has secured an 80 percent equity stake in Canadian organic and fair-trade coffee company Kicking Horse Coffee, in a deal worth CAD$215 million.

Featured In: Food News


FDA First: Keytruda Approved for Cancer Treatment Based on Biomarker Alone

May 25, 2017 - For the first time, the FDA has approved a cancer treatment for solid tumors based on the presence of a biomarker, as opposed to specifying a tissue of origin.

Featured In: Biotech News


One Year of Medically Assisted Dying in Canada

May 25, 2017 - In June of 2016, the federal government of Canada passed legislation to legalize medically assisted dying.

Featured In: Life Science News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Top 5 Most Impactful Tweets in Life Sciences During the Last Week

REGISTER FOR THESE WEBINARS

EU IVD Regulation: Top Five Changes for Medical Device Manufacturers to Consider


Thermal Processing Systems for the Food Industry: A Guide to Selecting Thermal Equipment and Technology


Rare Disease & Orphan Drug Development: Cost-Efficient Trial Design to Minimize Cash Burn


eTMF Workflows: Active eTMF to Improve the Quality of Clinical Trials


Copyright © 2016-2017 Honeycomb Worldwide Inc.